Humoral and cellular immunogenicity of COVID-19 booster dose vaccination in inflammatory arthritis patients

INTRODUCTION: Previous studies have shown a reduction in the effectiveness of primary COVID-19 vaccination in patients with rheumatic diseases. However, limited data is available regarding the effectiveness of the COVID-19 vaccine booster dose, especially on cellular response. The study aimed to ass...

Descripción completa

Detalles Bibliográficos
Autores principales: Wroński, Jakub, Jaszczyk, Bożena, Roszkowski, Leszek, Felis-Giemza, Anna, Bonek, Krzysztof, Kornatka, Anna, Plebańczyk, Magdalena, Burakowski, Tomasz, Lisowska, Barbara, Kwiatkowska, Brygida, Maśliński, Włodzimierz, Wisłowska, Małgorzata, Massalska, Magdalena, Ciechomska, Marzena, Kuca-Warnawin, Ewa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9659732/
https://www.ncbi.nlm.nih.gov/pubmed/36389719
http://dx.doi.org/10.3389/fimmu.2022.1033804

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9659732/
https://www.ncbi.nlm.nih.gov/pubmed/36389719
http://dx.doi.org/10.3389/fimmu.2022.1033804

Ejemplares similares